BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 12971827)

  • 1. Risk factors for high anti-HHV-8 antibody titers (> or =1:51,200) in black, HIV-1 negative South African cancer patients: a case control study.
    Wojcicki JM; Newton R; Urban MI; Stein L; Hale M; Patel M; Ruff P; Sur R; Bourboulia D; Sitas F
    BMC Infect Dis; 2003 Sep; 3():21. PubMed ID: 12971827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies against human herpesvirus 8 in black South African patients with cancer.
    Sitas F; Carrara H; Beral V; Newton R; Reeves G; Bull D; Jentsch U; Pacella-Norman R; Bourboulia D; Whitby D; Boshoff C; Weiss R
    N Engl J Med; 1999 Jun; 340(24):1863-71. PubMed ID: 10369849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of the frequency of antibody and titers against human herpesvirus 8 latent and lytic antigens in "at-risk" individuals and among patients with Kaposi's sarcoma.
    Magri MC; Carbone PH; de los Santos-Fortuna E; Caterino-de-Araujo A
    J Med Virol; 2009 Jul; 81(7):1292-7. PubMed ID: 19475629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of human sera reactivities in immunoblots with recombinant human herpesvirus (HHV)-8 proteins associated with the latent (ORF73) and lytic (ORFs 65, K8.1A, and K8.1B) replicative cycles and in immunofluorescence assays with HHV-8-infected BCBL-1 cells.
    Zhu L; Wang R; Sweat A; Goldstein E; Horvat R; Chandran B
    Virology; 1999 Apr; 256(2):381-92. PubMed ID: 10191203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of antibodies against latent and lytic antigens of human herpesvirus 8 in an endemic population and patients with Kaposi's sarcoma in Mozambique.
    Caterino-de-Araujo A; Magri MC; Manuel RC
    J Med Virol; 2010 Sep; 82(9):1576-81. PubMed ID: 20648612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of serologic responses between Kaposi's sarcoma-positive and -negative men who were seropositive for both human herpesvirus 8 and human immunodeficiency virus.
    Inoue N; Spira T; Lam L; Corchero JL; Luo W
    J Med Virol; 2004 Oct; 74(2):202-6. PubMed ID: 15332267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroreactivity to Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent nuclear antigen in AIDS-associated Kaposi's sarcoma patients depends on CD4+ T-cell count.
    de Souza VA; Pierrotti LC; Sumita LM; Freire WS; Segurado AA; Pannuti CS
    J Med Virol; 2007 Oct; 79(10):1562-8. PubMed ID: 17705173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The sero-epidemiology of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in adults with cancer in Uganda.
    Newton R; Ziegler J; Bourboulia D; Casabonne D; Beral V; Mbidde E; Carpenter L; Reeves G; Parkin DM; Wabinga H; Mbulaiteye S; Jaffe H; Weiss R; Boshoff C;
    Int J Cancer; 2003 Jan; 103(2):226-32. PubMed ID: 12455037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroprevalence of human herpesvirus 8 infection in individuals from health care centers in Mozambique: potential for endemic and epidemic Kaposi's sarcoma.
    Caterino-de-Araujo A; Manuel RC; Del Bianco R; Santos-Fortuna E; Magri MC; Silva JM; Bastos R
    J Med Virol; 2010 Jul; 82(7):1216-23. PubMed ID: 20513087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for Kaposi's sarcoma: a case-control study of HIV-seronegative people in Uganda.
    Ziegler J; Newton R; Bourboulia D; Casabonne D; Beral V; Mbidde E; Carpenter L; Reeves G; Parkin DM; Wabinga H; Mbulaiteye S; Jaffe H; Weiss R; Boshoff C;
    Int J Cancer; 2003 Jan; 103(2):233-40. PubMed ID: 12455038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kaposi's sarcoma in the Gambia, West Africa is less frequent in human immunodeficiency virus type 2 than in human immunodeficiency virus type 1 infection despite a high prevalence of human herpesvirus 8.
    Ariyoshi K; Schim van der Loeff M; Cook P; Whitby D; Corrah T; Jaffar S; Cham F; Sabally S; O'Donovan D; Weiss RA; Schulz TF; Whittle H
    J Hum Virol; 1998; 1(3):193-9. PubMed ID: 10195242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human herpesvirus 8 infection and Kaposi's sarcoma among human immunodeficiency virus-infected and -uninfected women.
    Greenblatt RM; Jacobson LP; Levine AM; Melnick S; Anastos K; Cohen M; DeHovitz J; Young MA; Burns D; Miotti P; Koelle DM
    J Infect Dis; 2001 Apr; 183(7):1130-4. PubMed ID: 11237842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human herpesvirus 8 presence and viral load are associated with the progression of AIDS-associated Kaposi's sarcoma.
    Laney AS; Cannon MJ; Jaffe HW; Offermann MK; Ou CY; Radford KW; Patel MM; Spira TJ; Gunthel CJ; Pellett PE; Dollard SC
    AIDS; 2007 Jul; 21(12):1541-5. PubMed ID: 17630548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients.
    Lennette ET; Blackbourn DJ; Levy JA
    Lancet; 1996 Sep; 348(9031):858-61. PubMed ID: 8826812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiological characteristics of human herpesvirus-8 infection in a large population of antenatal women in Zambia.
    Klaskala W; Brayfield BP; Kankasa C; Bhat G; West JT; Mitchell CD; Wood C
    J Med Virol; 2005 Jan; 75(1):93-100. PubMed ID: 15543582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral load of human herpesvirus 8 in peripheral blood of human immunodeficiency virus-infected patients with Kaposi's sarcoma.
    Tedeschi R; Enbom M; Bidoli E; Linde A; De Paoli P; Dillner J
    J Clin Microbiol; 2001 Dec; 39(12):4269-73. PubMed ID: 11724831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for Kaposi's-sarcoma-associated herpesvirus (KSHV/HHV-8) seropositivity in a cohort of homosexual men, 1981-1996.
    Melbye M; Cook PM; Hjalgrim H; Begtrup K; Simpson GR; Biggar RJ; Ebbesen P; Schulz TF
    Int J Cancer; 1998 Aug; 77(4):543-8. PubMed ID: 9679756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevalence of serum antibody to human herpesvirus 8 (Kaposi sarcoma-associated herpesvirus) among HIV-seropositive and high-risk HIV-seronegative women.
    Kedes DH; Ganem D; Ameli N; Bacchetti P; Greenblatt R
    JAMA; 1997 Feb; 277(6):478-81. PubMed ID: 9020272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demographic indicators and risk of infection with human herpesvirus type 8 in Central Italy.
    Valdarchi C; Serraino D; Cordiali Fei P; Castilletti C; Trento E; Farchi F; Rezza G;
    Infection; 2007 Feb; 35(1):22-5. PubMed ID: 17297585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sexual transmission and the natural history of human herpesvirus 8 infection.
    Martin JN; Ganem DE; Osmond DH; Page-Shafer KA; Macrae D; Kedes DH
    N Engl J Med; 1998 Apr; 338(14):948-54. PubMed ID: 9521982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.